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Veterinary service providers in Kenya and Tanzania are safely and more widely deploying a live East Coast fever 
(ECF) vaccine. The vaccine was produced by ILRI   in 1996-7 but its use was limited, requiring evidence 
demonstrating efficacy and safety.  
The research by ILRI and Tanzania partners was proposed in the 2003-2005 MTP and commenced in late 2002.  The 
outputs included an assessment of the efficacy and safety of a parasite-stabilate combined with 30% oxytetracylcline – 
the infection and treatment method (ITM).   
The safety and efficacy results from the studies by the ITTBDC-Tanzania and ILRI led to regulatory approval and 
widespread adoption in Tanzania through a private vaccine supplier, VetAgro-Tanzania. Independent research 
(Homewood et al), documented this adoption and its impact. Kenyan pastoralists noted the widespread and effective 
use of ITM in Tanzania and lobbied the Kenyan Government to allow them to use ITM. As a result, the Kenya 
Veterinary Department allowed NGOs to test ITM using the ILRI methodology, and have subsequently approved its 
use in pastoral areas of Kenya.  
Live vaccine demand has increased dramatically. VetAgro-Tanzania has requested 120,000 doses for 2007 and 
240,000 doses in 2008. This and demands in Kenya and other countries in East Africa will deplete the vaccine stock 
and require ILRI to produce more vaccine.  Private companies in Kenya together with The Global Alliance for Livestock 
Veterinary medicines (GALVmed) have shown keen interest in commercialising the vaccine through a private-public 
partnership. 
Evidence provided to the CGIAR: 
Homewood et al. 2006. Livestock health and socio-economic impacts of a veterinary intervention in 
Maasailand: Infection-and-treatment vaccine against East Coast fever.  Agricultural Systems 89(2-3):248-271 
found at www.elsevier.com/locate/agsy  
- Vaccine request from Tanzania 
- GALVmed project plans for 2007 
 
 
